Concern about the stockmarket’s overvaluation is going mainstream. For years now, those who have worried about the equity market’s overvaluation have been voices in the wilderness.
On the winning side of Wall Street were Novo Nordisk’s U.S.-listed shares, which jumped 8.6%. The Danish company reported results from a clinical trial of a treatment for people who are overweight or ...